Andrea Gissi

Andrea Gissi

European Chemicals Agency - Helsinki / Denmark
Others
AD Scientific Index ID: 4515101
-
person_outline Andrea Gissi's MOST POPULAR ARTICLES
1-) Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based PrioritizationK Paul Friedman, M Gagne, LH Loo, P Karamertzanis, T Netzeva, ...Toxicological Sciences 173 (1), 202-225, 2020902020
2-) REACH and in silico methods: an attractive opportunity for medicinal chemistsO Nicolotti, E Benfenati, A Carotti, D Gadaleta, A Gissi, GF Mangiatordi, ...Drug Discovery Today 19 (11), 1757-1768, 2014682014
3-) Evaluation and comparison of benchmark QSAR models to predict a relevant REACH endpoint: the bioconcentration factor (BCF)A Gissi, A Lombardo, A Roncaglioni, D Gadaleta, GF Mangiatordi, ...Environmental research 137, 398-409, 2015482015
4-) An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposesA Gissi, D Gadaleta, M Floris, S Olla, A Carotti, E Novellino, E Benfenati, ...ALTEX-Alternatives to animal experimentation 31 (1), 23-36, 2014532014
5-) Using toxicological evidence from QSAR models in practiceE Benfenati, S Pardoe, T Martin, RG Diaza, A Lombardo, A Manganaro, ...ALTEX-Alternatives to animal experimentation 30 (1), 19-40, 2013382013